A newly published, peer-reviewed study has dismantled the widely circulated claim that mifepristone—the first drug used in chemical abortions—is “safer than Tylenol.”
This assertion, repeated in courtrooms, media, and even by some health officials, has lacked rigorous evidence and now faces a serious scientific challenge.
The study exposes the flawed methodology behind such comparisons, noting that no direct, controlled studies support the claim. If such a statement were made by a pharmaceutical company, it would trigger FDA scrutiny for misleading advertising. Researchers argue the slogan misleads the public by ignoring the complex risks involved with abortion pills, especially when combined with misoprostol.
Read the study here.